Clinical Trials
24 trialsNivolumab and Ipilimumab in Treating Patients With Rare Tumors
National Cancer Institute (NCI)
TRANSCAPE
Case Comprehensive Cancer Center
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
University of Kentucky
Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surgery
CSL Behring
HIPEC-PMP
University of Southampton
Proactive Temperature Management in CRS-HIPEC for Prevention of Delirium
Aerospace Center Hospital
COCOON
Institut du Cancer de Montpellier - Val d'Aurelle
Pseudovax
Oslo University Hospital
One vs Three HIPEC Cycles After CRS for Pseudomyxoma Peritonei
Beijing Tsinghua Chang Gung Hospital
Flura-seq for Evaluating the Effects of Different Hyperthermic Intraperitoneal Chemotherapy Regimens on the Transcriptome of Pseudomyxoma Peritonei
Beijing Tsinghua Chang Gung Hospital
A Study of SGN-STNV in Advanced Solid Tumors
Seagen Inc.
REVERSE
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Mercy Medical Center
HIPEC for Peritoneal Carcinomatosis
Albert Einstein College of Medicine
Gastrointestinal Microbiome Study of Appendiceal Cancer
Mercy Medical Center
Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei
Maimónides Biomedical Research Institute of Córdoba
Phase I Trial HIPEC With Nal-irinotecan
Stony Brook University
ACAPP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
BromAc for Recurrent Peritoneal Mucinous Tumour or Pseudomyxoma Peritonei
Mucpharm Pty Ltd
HOPE
Wake Forest University Health Sciences
HIPEC-IAP
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
Ohio State University Comprehensive Cancer Center
Carboplatin, Gemcitabine Hydrochloride, and Stereotactic Body Radiation Therapy in Gynecological Cancer
Case Comprehensive Cancer Center
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
National Cancer Institute (NCI)